Camille Sebaaly

2021

In 2021, Camille Sebaaly earned a total compensation of $346K as Chief Financial Officer at Sunshine Biopharma.

Compensation breakdown

Salary$40,000
Stock Awards$306,000
Total$346,000

Sebaaly received $306K in stock awards, accounting for 88% of the total pay in 2021.

Sebaaly also received $40K in salary.

Rankings

In 2021, Camille Sebaaly's compensation ranked 11,427th out of 12,415 executives tracked by ExecPay. In other words, Sebaaly earned more than 8.0% of executives.

ClassificationRankingPercentile
All
11,427
out of 12,415
8th
Division
Manufacturing
5,034
out of 5,505
9th
Major group
Chemicals And Allied Products
2,232
out of 2,375
6th
Industry group
Drugs
1,982
out of 2,096
5th
Industry
Pharmaceutical Preparations
1,466
out of 1,546
5th
Source: SEC filing on October 18, 2023.

Sebaaly's colleagues

We found two more compensation records of executives who worked with Camille Sebaaly at Sunshine Biopharma in 2021.

2021

Steve Slilaty

Sunshine Biopharma

Chief Executive Officer

2021

Abderrazzak Merzouki

Sunshine Biopharma

Chief Operating Officer

News

You may also like